Switch to:
Repros Therapeutics Inc (NAS:RPRX)
EV/Revenue
2,631.36 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Repros Therapeutics Inc's enterprise value is $28.95 Mil. Repros Therapeutics Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2016 was $0.01 Mil. Therefore, Repros Therapeutics Inc's EV/Revenue ratio for today is 2,631.36.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Repros Therapeutics Inc's stock price is $1.54. Repros Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2016 was $0.00. Therefore, Repros Therapeutics Inc's P/S Ratio for today is .


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Repros Therapeutics Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=28.945/0.011
=2,631.36

Repros Therapeutics Inc's current Enterprise Value is $28.95 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Repros Therapeutics Inc's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was $0.01 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Repros Therapeutics Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=1.54/0
=

Repros Therapeutics Inc's share price for today is $1.54.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Repros Therapeutics Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Repros Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2rev 203.6661.68520.5033.5157.4627,505.1082,019.3343,159.5024,431.45730.38

Repros Therapeutics Inc Semi-Annual Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2rev 33,915.0020,501.7824,431.4524,384.3123,575.3330,901.52730.38279.42649.88840.33
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK